ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,957Gold OA

Eye and Vision

Acronym:eavi
•
Abbreviation (ISO):EYE VISION
•
Identifier (ISSN):2326-0254(Print)
•
Publisher:BioMed Central
Clarivate IF (2026)
5.2↑ +1.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Eye and Vision

WoS Q1
0257020182.6820192.2420203.2620214.4320224.220234.12024420255.22026
Annual Impact Factor Metric
Current (2026):5.2
Scopus SJR & RankScopus Q1
1.693
#1,957

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
52

52 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate2.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
46articles/year
100% Gold OA•93.48% Original Research

Aims & Scope

Eye and Vision is an open access, peer-reviewed journal for ophthalmologists and visual science specialists. It welcomes research articles, reviews, methodologies, commentaries, case reports, perspectives and short reports encompassing all aspects of eye and vision. Topics of interest include but are not limited to: current developments of theoretical, experimental and clinical investigations in ophthalmology, optometry and vision science which focus on novel and high-impact findings on central issues pertaining to biology, pathophysiology and etiology of eye diseases as well as advances in diagnostic techniques, surgical treatment, instrument updates, the latest drug findings, results of clinical trials and research findings. It aims to provide ophthalmologists and visual science specialists with the latest developments in theoretical, experimental and clinical investigations in eye and vision.

Topics Covered (Recognized by AI)
Medicine97.5%Ophthalmology89.8%Biology89.2%Physics81.9%Optics79.4%Psychology74.6%Surgery71.7%Neuroscience63.2%Internal medicine53.3%Visual acuity48.6%Chemistry42.5%Biochemistry36.8%Cornea35.9%Genetics34.9%Pathology34%Mathematics27.6%Optometry27.6%Radiology27.3%Psychiatry25.7%Botany22.5%Quantum mechanics21.6%Retinal21.6%Computer science20.6%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

OPHTHALMOLOGY

Q1
Rank11/98
IndexSCIE
JCISCIE2026

OPHTHALMOLOGY

Q1
Rank9/98
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.2
Articles / Year27
Total Citations9
2025
IF4
Articles / Year51
Total Citations169
2024
IF4.1
Articles / Year49
Total Citations464
2023
IF4.2
Articles / Year50
Total Citations768
2022
IF4.427
Articles / Year46
Total Citations1,037

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,957Scopus Q1SCImago Profile
Scopus Coverage:2014-2026
Scopus Broad Areas:Health ProfessionsMedicine
Scopus Citation Rank (SJR)Q1
1.693

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.56

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,603 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations821
3-Year Documents139
Citable Documents139

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Health Professions (miscellaneous)Q1
OphthalmologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区OPHTHALMOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Eye and Vision (acronym: eavi, abbr: EYE VISION, ISSN: 2326-0254) is a peer-reviewed international scholarly journal in the field of OPHTHALMOLOGY, published by BioMed Central in Netherlands since 2014. The periodical holds a Journal Impact Factor (JIF) of 5.20, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.693 (Q1), an H-index of 52.

The journal enforces rigorous peer evaluation with an annual output of approximately 46 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,603 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
BioMed Central
Publication Language
English
Frequency
Periodic
Founding Year
2014
Indexing & Databases
SCIEDOAJPubMed
Editorial Address
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b8f0718b-d345-4c11-ba82-69d5edd0e9eb
Database Updated: 2026-10-01